AzTrials
AzTrials

Oxygenation IndexPhase 4NCT06359106

Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia

A Phase 4 study testing 80% Oxygen and 40% Oxygen in people with Oxygenation Index, run by China Medical University, China at 16 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Oxygenation Index
What is being tested?
80% Oxygen and 40% Oxygen
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
1,176 participants
Where
16 sitesChina
Study dates
2 Jul 2024to 30 Jun 2026
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age not less than 65 years
  • American Society of Anesthesiologists grades I-III
  • No history of drug allergies or abnormal anesthesia.
  • The duration of mechanical ventilation was expected to be more than 2 hours.
  • Laparoscopic Gastrointestinal Surgery
  • The preoperative oxygen saturation was not less than 94%.
  • The patients will be planned to extubate in the operating room.

Who cannot join

  • History of acute lung injury or acute respiratory distress syndrome (ARDS) within 3 months.
  • Cardiac function Class IV (New York Heart Association classification)
  • Chronic renal failure (renal cell filtration rate <30 ml min-11.73/m2), severe liver disease
  • Patients with blurred consciousness and cognitive dysfunction
  • Severe coagulation dysfunction.
  • Without preoperative oxygen inhalation, blood oxygen level <94%, and severe pulmonary dysfunction
Show all 9Show fewer
  • Patients with endotracheal tubes were admitted to the intensive care unit (ICU) after surgery.
  • Body mass index (BMI) >30kg/m2
  • Inability to complete the study

Trial locations and contacts

16 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Tianhao Zhang, M.D. contact

+862483283100

zhth774176947@163.com

Yang An, M.D. contact

+862483283100

cmu_ay2016@163.com

16 sites in 1 country

China16 sites, 16 recruiting
  • Beijing Friendship Hospital, Capital Medical University

    Beijing

    Yun Wang

    Recruiting
  • Sichuan Provincial People's Hospital

    Chendu

    Qian Lei

    Recruiting
  • Chifeng Municipal Hospital

    Chifeng

    Jiannan Song

    Recruiting
  • Dalian Third People's Hospital

    Dalian

    Shiling Zhao

    Recruiting
  • First Affiliated Hospital, Dalian Medical University

    Dalian

    Yong Luan

    Recruiting
  • First Affiliated Hospital of Harbin Medical University

    Harbin

    Kun Wang

    Recruiting
  • Harbin Medical University Cancer Hospital

    Harbin

    Fei Han

    Recruiting
  • First Medical University and Shandong Provincial Qianfoshan Hospital

    Jinan

    Jianbo Wu

    Recruiting
  • First Affiliated Hospital of Kunming Medical University

    Kunming

    Jianlin Shao

    Recruiting
  • Affiliated Hospital of Qingdao University

    Qingdao

    Wei Feng

    Recruiting
  • the First Hospital of China Medical University

    Shenyang, Liaoning, 110001

    Wenfei Tan, M.D.,Ph.D, 024-83283100, winfieldtan@hotmail.com

    Recruiting
  • Liaoning Cancer Hospital and Institute

    Shenyang

    Zeqing Huang

    Recruiting
  • Shenzhen People's Hospita

    Shenzhen

    Chaoran Wu

    Recruiting
  • First Hospital of Hebei Medical University

    Shijia Zhuang

    Li Wang

    Recruiting
  • Second Hospital of Hebei Medical University

    Shijia Zhuang

    Lining Huang

    Recruiting
  • YANBIAN University Hospital(Yanbian Hospital)

    Yanbian

    Yongshan Nan

    Recruiting

Other trials in China

About this study

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery.

Read the detailed description

This was a multicenter, prospective, parallel-grouping, randomized controlled clinical study comparing low FiO2 (40%) and high FiO2 (80%) levels in older patients undergoing laparoscopic gastrointestinal surgery. the investigators planned to enroll 1098 subjects aged > 65 years for laparoscopic gastrointestinal surgery at 19 clinical trial centers in China, randomized in a 1:1 ratio, to use two inhaled oxygen concentrations during surgery. All patients will be performed via the lung-protective ventilation strategy. The respiratory parameters are VT: 6-8ml/kg, PEEP: 6-8 cmh2O, RR: 1:2, and respiratory rate will be adjusted by maintaining a partial pressure of carbon dioxide at 35-45 mmHg. Manual lung recruitment maneuvers will be performed after tracheal intubation and before tracheal extubation. The main outcome measure was the oxygenation index on the postoperative 48h. The secondary outcome measures were the 7-day postoperative pulmonary complications and 30-day mortality rates et al.

Being tested
80% Oxygen, 40% Oxygen

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 80% OxygenDrug

    After successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 80%, and the total gas flow rate will be set at 2L/minute.

  • 40% OxygenDrug

    After successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 40%, and the total gas flow rate will be set at 2L/minute.

Study groups in NCT06359106
Study groupRoleWhat they receive
Control: 80% OxygenPlacebo comparatorBefore anesthesia induction, the participants inhaled 100% oxygen through the mask for 3 minutes. After successful anesthesia induction, the fraction of inspired oxygen (FiO2) will be adjusted to 80%, and the total gas flow rate will be set at 2L/minute. All patients will receive treatment through the lung-protective ventilation strategy. The respiratory parameters are VT: 6-8mL/kg, positive end-expiratory pressure (PEEP), 6-8 cmH2O; RR: 1:2, and respiratory rate will be adjusted by maintaining a partial pressure of carbon dioxide at 35-45 mmHg. Manual lung recruitment maneuvers will be performed after tracheal intubation and before tracheal extubation. Blood will be collected for blood gas analysis within 48 hours after surgery.
Receives: Drug: 80% Oxygen
Experimental: 40% OxygenExperimentalBefore anesthesia induction, the participants inhaled 100% oxygen through the mask for 3 minutes. After successful anesthesia induction, FiO2 will be adjusted to 40%, and the total gas flow rate will be set at 2L/minute. All patients will receive treatment through the lung-protective ventilation strategy. The respiratory parameters are VT: 6-8mL/kg, positive end-expiratory pressure (PEEP), 6-8 cmH2O; RR: 1:2, and respiratory rate will be adjusted by maintaining a partial pressure of carbon dioxide at 35-45 mmHg. Manual lung recruitment maneuvers will be performed after tracheal intubation and before tracheal extubation. However, when intraoperative oxygen saturation is less than 94%, the manual lung recruitment maneuver will also be performed. Patients should transfer to 80% Oxygen group if intraoperative oxygen saturation less than 85%.Blood will be collected for blood gas analysis within 48 hours after surgery.
Receives: Drug: 40% Oxygen

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygenation Index

    The primary outcome was the comparison of the oxygenation index between the two groups. Oxygenation index of acute lung injury is 200, and higher scores mean worse outcome.

    Measured: On the postoperative 48th hour

Secondary outcomes (8)
  1. pH value in blood gas analysis 48 hours after the operation

    pH of blood gas analysis 48 hours after the operation

    Measured: On the postoperative 48th hour

  2. oxygen inhalation time

    oxygen inhalation time

    Measured: On the postoperative 48 hour

  3. inspired oxygen concentration

    inspired oxygen concentration

    Measured: On the postoperative 48 hour

  4. oxygen uptake rate

    oxygen uptake rate

    Measured: On the postoperative 48 hour

  5. 7 days pulmonary complications

    7 days pulmonary complications

    Measured: On the postoperative 7th day

  6. 30-day Mortality

    30-day Mortality

    Measured: On the postoperative 30th day

  7. PaCO2 in blood gas analysis 48 hours after the operation

    PaCO2 of blood gas analysis 48 hours after the operation

    Measured: On the postoperative 48th hour

  8. Lactic acid in blood gas analysis 48 hours after the operation

    Lactic acid in blood gas analysis 48 hours after the operation

    Measured: On the postoperative 48th hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2024
  2. Study start2 Jul 2024
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
1,176 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06359106
Sponsor's protocol ID
2024.3.1
Status last verified
Jan 2026
First submitted
26 Mar 2024
Last updated
26 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study Protocol and Statistical Analysis Plan will be published

Publications

  • Zhang T, An Y, Zhao S, Han F, Huang L, Wang L, Wu J, Lei Q, Wang K, Shao J, Wang Y, Luan Y, Feng W, Song J, Huang Z, Wu C, Nan Y, Tang B, Sun X, Tan W. Effects of varying inhaled oxygen concentrations on lung function in older adult patients undergoing laparoscopic gastrointestinal surgery under general anesthesia: protocol of a prospective multicenter clinical study in China. Trials. 2026 Jan 23;27(1):139. doi: 10.1186/s13063-026-09471-3.

    PubMed 41572351

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing 80% Oxygen and 40% Oxygen in people with Oxygenation Index, run by China Medical University, China at 16 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 16 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tianhao Zhang, M.D. (+862483283100, zhth774176947@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygenation Index (time frame: On the postoperative 48th hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06359106, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in